Breakthrough cancer treatment prevented leukemia for 10 years, study shows

Breakthrough cancer treatment prevented leukemia for 10 years, study shows
Undated handout photo issued by Queen’s University Belfast of research in the university’s Centre for Cancer Research & Cell Biology (Queen’s University Belfast/PA)

A breakthrough cancer treatment can prevent the recurrence of leukemia for at least 10 years, a new study shows.

The paper, published in the journal Nature, showed that two patients who were followed for a decade after beginning a trial of Chimeric Antigen Receptor (CAR) T-cell therapy in 2010 have been in remission since starting.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited